Stephan Moll, MD writes… A clinical research study is being conducted in the U.S. for the treatment of chronic deep vein thrombosis (DVT) with post-thrombotic syndrome (PTS) and is open for enrollment. It is referred to as ACCESS-PTS. It includes a treatment using the EkoSonic® Endovascular System – an FDA-cleared device that delivers clot-dissolving drugs (thrombolytic drugs) to the old clot. The purpose of this research study is to evaluate how successful this treatment is in patients with clots that are at least 6 months old and have not been responsive to traditional treatments such as elastic compression stockings and blood thinning drugs (anticoagulants).
Patients may be eligible for the study if they have been diagnosed with leg DVT 6 or more months ago and are currently experiencing PTS symptoms that impact the quality of life. Some of the symptoms of PTS include:
- Skin Redness and Discoloration
- Tingling or numbness
- Swelling and Heaviness
- Chronic Pain
- Skin Ulcerations
You can go to www.chronicdvtstudy.com and to www.clinicaltrials.gov (and put into the “SEARCH” filed the clinical trial identifier: NCT02159521) for more information about the study. The overall responsible physician for this study is Dr. Mark Garcia, Chief of Vascular & Interventional Radiology of Christiana Health Care System in Newark, Delaware (details here).
www.clinicaltrials.gov: clinical trial identifier: NCT02159521
Disclosures: I have no conflict of interest
Last Updated: July 15th, 2015